


Cybrexa Therapeutics Email Formats
Biotechnology Research • New Haven, Connecticut, United States • 11-20 Employees
Cybrexa Therapeutics Email Formats
Cybrexa Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@cybrexa.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@cybrexa.com | 50% |
{first name}.{last name} | john.doe@cybrexa.com | 50% |
Key Contacts at Cybrexa Therapeutics
Emily Reda
Sales Director
Waren Tolentino
Sales Director
Victor Facchini
Director, Fp&A
Company overview
| Headquarters | 5 Science Park, New Haven, CT 06511, US |
| Phone number | +18607991517 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Oncology, Drug Development, Biotech, Phase I, DDR, Parp Inhibitor |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
About Cybrexa Therapeutics
Cybrexa is a clinical-stage oncology biotechnology company developing novel antigen-independent peptide drug conjugates (ADCs) aimed at combatting a range of cancer types, including ovarian, breast and non-small cell lung cancer. With the potential to disrupt the standard of care, the Cybrexa alphalex™ technology is a novel antigen-independent peptide drug conjugate (PDC) platform that enables targeted delivery of highly potent anticancer treatments and aims to revolutionize the standard of care in oncology. The platform consists of a pHLIP® peptide, linker, and small molecule anti-cancer agent.pHLIP® peptides are a family of pH-Low Insertion Peptides that target acidic cell surfaces.pHLIP® was developed at Yale University and the University of Rhode Island, and is exclusively licensed to pHLIP, Inc.alphalex™ represents the disruptive next generation in tumor targeting.Early clinical trials of the company’s lead candidate, CBX-12, demonstrate robust efficacy signals and tolerability in patients with metastatic cancer. As a privately held company, Cybrexa is led by a management team experienced at building life science companies and driven by scientists with an expertise in drug development and oncology. For more information, visit www.cybrexa.com. Community Guidelines: https://bit.ly/3GI6AU0
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Cybrexa Therapeutics has 7 employees across 4 departments.
Departments
Number of employees
Cybrexa Therapeutics Tech Stack
Discover the technologies and tools that power Cybrexa Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Analytics
UI frameworks
WordPress themes
SEO
Frequently asked questions
4.8
40,000 users



